Deevyalok Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 09-12-2024
- Paid Up Capital ₹ 6.65 M
as on 09-12-2024
- Company Age 40 Year, 10 Months
- Last Filing with ROC 31 Mar 2013
- Open Charges ₹ 2.36 Cr
as on 09-12-2024
About Deevyalok Pharma
The Corporate was formerly known as Syntho Rifa Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2013. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.65 M.
The company currently has active open charges totaling ₹2.36 Cr.
Chhailbihari Upadhyay, Kamalahmad Khan, Haresh Machhi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100MH1984PTC032423
- Company No.
032423
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Mar 1984
- Date of AGM
28 Sep 2013
- Date of Balance Sheet
31 Mar 2013
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Deevyalok Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chhailbihari Upadhyay  | Director | 01-Dec-2006 | Current |
| Kamalahmad Khan | Director | 18-Sep-2007 | Current |
| Haresh Machhi | Director | 01-Dec-2006 | Current |
| Kamlesh Jaiswal | Director | 18-Sep-2007 | Current |
| Vimal Upadhyay | Director | 06-Dec-2007 | Current |
Financial Performance of Deevyalok Pharma.
Enhance accessibility to Deevyalok Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Deevyalok Pharma?
Unlock access to Deevyalok Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹23.60 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 2.36 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2008 | Bank Of Baroda | ₹1.18 Cr | Open |
| 22 Aug 2008 | Bank Of Baroda | ₹1.18 Cr | Open |
How Many Employees Work at Deevyalok Pharma?
Unlock and access historical data on people associated with Deevyalok Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deevyalok Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deevyalok Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
